Active substance
Dimethindene
- SFDA 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| FENISTIL DROPS 0.1G-100ML | 1 mg/ml | Drops · Oral use | 1 Bottle | SAR 14.45 | NCE · OTC | Haleon Schweiz AG | Valid |
| FENISTIL GEL | 1 mg | Gel · Topical | 1 Tube | SAR 12.30 | NCE · OTC | Haleon Schweiz AG | Valid |
| Sineo | 1 mg/ml | Oral drops · Oral use | 1 Bottle | SAR 9.05 | Generic · Prescription | ALPHA PHARMA INDUSTRY | Valid |
| FENISTIL 1 MG COATED TAB | 1 mg | Tablet · Oral use | 20 Blister | SAR 9.40 | NCE · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
| FENISTIL 24 LONG ACTING CAPSULE 4 MG | 24 mg | Capsule · Oral use | 10 Blister | SAR 13.65 | NCE · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
| FENISTIL SYRUP | 0.1 mg/ml | Syrup · Oral use | 1 Bottle | SAR 16.60 | NCE · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
HUMAN IMMUNODEFICIENCY VIRUS; TUBERCULOSIS-SUPPORTIVE CARE
Combinations containing Dimethindene
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.